Learn more about whether Immunocore Holdings plc or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The cosmetics and personal care segment remains the dominant end-use area, capturing 50.6% of market share in 2025.

Exclusive data analysis carried out by FutureBridge on behalf of Food Manufacture has identified the top 100 hottest food and ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

"Adapt or perish, now as ever, is nature's inexorable imperative," wrote H. G. Wells. This principle—that survival requires ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

The gut microbiome serves as both a biomarker and therapeutic target in diseases like obesity, metabolic syndrome, and ...

Leading Edge Health's GenuinePurity brand addresses authentication challenges and bioavailability concerns with certificate of authenticity protocols, third-party laboratory verification, and ...

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...